deltatrials
Completed PHASE3 NCT00973154

Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial

Corticosteroid Treatment for Community-Acquired Pneumonia A Randomized, Double-blind Study- The STEP Trial

Sponsor: Kantonsspital Aarau

Conditions Community-acquired Pneumonia
Interventions Prednisone
Updated 5 times since 2017 Last updated: Apr 20, 2015 Started: Dec 31, 2009 Primary completion: Jul 31, 2014 Completion: Dec 31, 2014

Listed as NCT00973154, this PHASE3 trial focuses on Community-acquired Pneumonia and remains completed. Sponsored by Kantonsspital Aarau, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kantonsspital Aarau
  • Kantonsspital Liestal
  • University Hospital, Basel, Switzerland
Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Aarau, Switzerland
  • • Basel, Switzerland
  • • Bern, Switzerland
  • • Bruderholz, Switzerland
  • • Delémont, Switzerland
  • • Liestal, Switzerland
  • • Solothurn, Switzerland